Skip to Content

Consolidated Cash flow Statement

for the year ended 31 December

In € millions

Note

2025

2024

Cash flows from operating activities

Result for the period

208

242

Adjustments for:

Depreciation and amortization

14,15,16

106

111

Amortization other identifiable intangible assets

14

25

29

Income taxes

12

73

97

Net finance expense

11

40

53

Result from Investments accounted for using the equity method

17

(5)

(3)

Adjusted profit for the period (EBITDA)1

448

529

Change in Inventories

(0)

0

Change in Contract assets and liabilities, provision for onerous contracts

(13)

(20)

Change in Trade receivables

81

(12)

Change in Accounts payable

38

(21)

Change in Net working capital

105

(53)

Change in Other receivables

(20)

14

Change in Current liabilities

(21)

6

Change in Other working capital

(41)

20

Change in Provisions

27,28

8

(15)

Share-based compensation

10

8

8

(Gain)/ loss on divestments

8

3

(2)

(Gain)/ loss on sale of assets

1

-

Result on derecognition of leases

0

(0)

Change in operational derivatives

(0)

(1)

Settlement of operational derivatives

-

-

Dividend received

0

3

Interest received

35

8

Interest paid

(79)

(52)

Corporate tax paid

(102)

(95)

Net cash generated from operating activities

386

350

1 Non-GAAP performance measure. Reference is made to the for the definition as used by Arcadis and to the for the reconciliation tables.

In € millions

Note

2025

2024

Cash flows from investing activities

Investments in (in)tangible assets

14,15

(25)

(45)

Proceeds from sale of (in)tangible assets/ reversal of non-cash items

1

0

Investments in consolidated companies

6

(84)

(2)

Proceeds from sale of consolidated companies

6

-

1

Investments in/ loans to associates and joint ventures

17

-

(0)

Proceeds from (sale of) associates and joint ventures

17

0

0

Investments in other non-current assets and other investments

18,20

(2)

(2)

Proceeds from (sale of) other non-current assets and other investments

18,20

1

2

Net cash used in investing activities

(109)

(46)

Cash flows from financing activities

Purchase of own shares

25

(136)

(51)

Settlement of financing derivatives

19

(3)

9

New long-term loans and borrowings

29

260

95

Repayment of long-term loans and borrowings

29

(210)

(116)

New short-term borrowings

29

110

60

Repayment of short-term borrowings

29

(191)

(60)

Payment of lease liabilities

16

(74)

(78)

Dividends paid to shareholders

(89)

(76)

Net cash used in financing activities

(333)

(218)

Net change in Cash and cash equivalents less Bank overdrafts

(55)

86

Exchange rate differences

(41)

9

Cash and cash equivalents less Bank overdrafts at 1 January

375

280

Cash and cash equivalents less bank overdrafts available to the Group at 31 December

279

375

Cash held on behalf of factor

24

15

-

Cash and cash equivalents less Bank overdrafts at 31 December

294

375

Download the full report here Download here